Assistant Editor: Special
Assignments
JULIA AALBERS
TEL: (021) 976-4378
FAX: 086 610 3395
e-mail:
Development Editor:
GLENDA HARDY
CELL: 071 819 6425
FAX: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
TEL: (021) 785-7178
FAX: 086 628 1197
e-mail:
Editorial Assistant and
Circulation
ELSABÉ BURMEISTER
TEL/FAX: (021) 976-8129
e-mail:
Production Co-ordinator
WENDY WEGENER
TEL: (021) 976-4378
e-mail:
Content Manager
MICHAEL MEADON
(
Design Connection)
TEL: (021) 975-3785
FAX: 0866 557 149
e-mail:
The
South African Journal of
Diabetes and Vascular Disease
is
published four times a year for
Clinics Cardive Publishing (Pty)
Ltd and printed by Tandym
Print. Online Services: Design
Connection.
Articles in this Journal are
sourced as per agreement with
the British Journal of Diabetes
and Vascular Disease
All correspondence to be
directed to:
THE EDITOR
PO BOX 1013
DURBANVILLE
7551
or
TEL/FAX: (021) 976-8129
INT: 2721 976-8129
Full text articles available on:
via
The opinions, data and statements
that appear in any articles
published in this journal are those
of the contributors. The publisher,
editors and members of the
editorial board do not necessarily
share the views expressed herein.
Although every effort is made
to ensure accuracy and avoid
mistakes, no liability on the part of
the publisher, editors, the editorial
board or their agents or employees
is accepted for the consequences
of any inaccurate or misleading
information.
Evidence in Practice
125
Early cardiac risk markers in diabetic African patients
126
Left ventricular remodelling after antihypertensive treatment
Salt intake falling: still too high
127
Can very low-calorie diets reverse diabetes?
Success with childhood anti-obesity
programmes
Reports
128
ADAWatch, 2012 update from Philadelphia, USA
L Lombard, D Jivan, J Aalbers
134
22
nd European meeting on hypertension and cardiovascular protection,
London 2012
N Rapeport, S Middlemost
135
Southern African Hypertension Society congress report, March 2012
The young hypertensive
G Hardy
136
Southern African Hypertension Society congress report, March 2012
Management of type 2 diabetes in primary healthcare
W Mollentze
Drug Trends
137
ORIGIN trial shows safety and efficacy of insulin glargine: no adverse
cardiovascular outcomes after a 6.2-year follow up of early insulin use
L Lombard, L Distiller, J Aalbers
141
Managing neuropathic pain: first expert recommendation for South Africa
places emphasis on stepwise pharmacological intervention
J Aalbers
144
Saxagliptin efficacy and safety in special patient groups (the elderly and
those with renal impairment)
J Aalbers
